During the past decade, Klinikum Ernst von Bergmann gemeinnützige GmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikum Ernst von Bergmann gemeinnützige GmbH" are "Arterio-Venous Fistula" (1 trials), "Arteriovenous Fistula Thrombosis" (1 trials), "Chemotherapy-induced Nausea and Vomiting" (1 trials), "ESRD" (1 trials) and "Kidney Diseases" (1 trials). Many other conditions were trialed in "Klinikum Ernst von Bergmann gemeinnützige GmbH" in a lesser frequency.

Most popular intervention types in "Klinikum Ernst von Bergmann gemeinnützige GmbH" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone, 8 mg (oral) or equivalent IV dose" (1 trials), "Granisetron, 2 mg (oral) or 1 mg (IV) OR Palonosetron, 0.5 mg (oral), 0.25mg (IV) OR Ondansetron, 16 mg (oral) or 8 mg (IV) OR Dolasetron 100 mg (oral) OR Tropisetron 5 mg (oral or IV)" (1 trials), "NEPA (300mg netupitant/0.5mg palonosetron)" (1 trials) and "VasQ" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Ernst von Bergmann gemeinnützige GmbH" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Ernst von Bergmann gemeinnützige GmbH". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinikum Ernst von Bergmann gemeinnützige GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Ernst von Bergmann gemeinnützige GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".